KF-20444
KF-20444 is an orally active ALK inhibitor with the ability to penetrate the blood-brain barrier. It exhibits potent inhibitory effects on ALK fusion proteins (EML4-ALK) and ALK-resistant mutations, including L1196M, G1202R, and F1174L. KF-20444 effectively suppresses the phosphorylation of ALK in cancer cell lines driven by ALK, thereby inhibiting cancer cell proliferation and inducing apoptosis (apoptosis) . In mouse models bearing ALK-positive non-small cell lung cancer or neuroblastoma, it demonstrates antitumor efficacy. KF-20444 is applicable for research into ALK-driven malignancies.
Product Specifications
CAS Number
154015-73-3
Smiles
O=C (O) C=1C=2C=C (F) C=CC2N=C3C=4C=CC (=CC4CCCC31) C=5C=CC=CC5F
Molecular Formula
C25H17F2NO2
Molecular Weight
401.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
VEGFR2 (VEGF Receptor 2, VEGFR 2, Vascular Endothelial Growth Factor Receptor 2, VEGFR-2, VEGFR, CD309 Antigen, Fetal Liver Kinase 1, FLK1, Kinase Insert Domain Receptor, KDR, KRD1, Ly73, Protein Tyrosine Kinase Receptor FLK1) (MaxLight 650) discontinued
Human Ataxia Telangiectasia Mutated (ATM) ELISA Kit